Progesterone Receptor Negative Recruiting Phase 1 / 2 Trials for Carboplatin (DB00958)

IndicationStatusPhase
DBCOND0038639 (Progesterone Receptor Negative)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03853707Ipatasertib and Carboplatin With or Without Paclitaxel in Treating Patients With Metastatic Triple Negative Breast CancerTreatment